Imagion Biosystems Ltd.ASX: IBX

Imagion Biosystems: Results of General Meeting

Aug 9, 2026 at 10:42 PM EDT · Issued by Imagion Biosystems Ltd. via ASX

Filed with ASX · Aug 9, 2026 at 10:42 PM EDT

On 6ix: 6ix.com/news/results-of-general-meeting-210

Imagion Biosystems Limited ASX: IBX Imagion Biosystems Limited ASX: IBX ACN 616 305 027 Suite 2, Level 11 385 Bourke Street Melbourne VIC 3000 imagionbiosystems.com | [email protected] A S X A N N O U N C E M E N T | 1 0 A U G U S T 2 0 2 6 ASX Market...

View Attachment

6ix hasn’t read this filing yet.

Imagion Biosystems Ltd. on 6ix

Earlier from Imagion Biosystems

Appendix 4C and Quarterly Activities Report - June 2026Jul 30
Proposed issue of securities - IBXJul 28
Non-Dilutive Short-Term Funding SecuredJul 28
Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical TrialJun 25
IBX Secures Firm Commitments for $3.75m for Clinical TrialJun 24

Later from Imagion Biosystems

Application for quotation of securities - IBXAug 17
Cleansing NoticeAug 17
Appendix 4D and Half-yearly Financial ReportAug 24
Change of Director's Interest Notices - RP, BM, NWAug 25
IBX Phase 2 Clinical Trial UpdateAug 25

All Imagion Biosystems news releases

Follow Imagion Biosystems into a list and get an email when it puts out news.

Follow Imagion Biosystems